Publicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (121)

2024

  1. ANKK1 Is a Wnt/PCP Scaffold Protein for Neural F-ACTIN Assembly

    International Journal of Molecular Sciences, Vol. 25, Núm. 19

2023

  1. Failure of deactivation in bipolar disorder during performance of an fMRI adapted version of the Stroop task

    Journal of Affective Disorders, Vol. 329, pp. 307-314

2021

  1. Activation and deactivation patterns in schizophrenia during performance of an fMRI adapted version of the stroop task

    Journal of Psychiatric Research, Vol. 144, pp. 1-7

2020

  1. Staging of depressive disorders: Relevance of resistance to treatment and residual symptoms

    Journal of Psychiatric Research, Vol. 129, pp. 234-240

2019

  1. CIBERSAM: Ten years of collaborative translational research in mental disorders

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 1, pp. 1-8

2016

  1. Facial affect recognition in early and late-stage schizophrenia patients

    Schizophrenia Research, Vol. 172, Núm. 1-3, pp. 177-183

2015

  1. Are negative symptoms really related to cognition in schizophrenia?

    Psychiatry Research, Vol. 230, Núm. 2, pp. 377-382

  2. Desarrollo profesional en investigación traslacional en neurociencias y salud mental: educación y formación dentro del Centro de Investigación Biomédica en Red en Salud Mental

    Revista de Psiquiatria y Salud Mental, Vol. 8, Núm. 2, pp. 65-74

  3. The MCCB impairment profile in a Spanish sample of patients with schizophrenia: Effects of diagnosis, age, and gender on cognitive functioning

    Schizophrenia Research, Vol. 169, Núm. 1-3, pp. 116-120

2014

  1. Differential relationships between set-shifting abilities and dimensions of insight in schizophrenia

    Psychopathology, Vol. 47, Núm. 2, pp. 86-92

  2. Hypothesizing dopaminergic genetic antecedents in schizophrenia and substance seeking behavior

    Medical Hypotheses, Vol. 82, Núm. 5, pp. 606-614

  3. Is it possible to combine different psychotic symptom scales in bipolar disorder?

    Psychiatry Research, Vol. 220, Núm. 3, pp. 1090-1093

  4. Neurocognition, social cognition and functional outcome in schizophrenia

    European Journal of Psychiatry, Vol. 28, Núm. 4, pp. 201-211

2013

  1. Cognition and the five-factor model of the Positive and Negative Syndrome Scale in schizophrenia

    Schizophrenia Research, Vol. 143, Núm. 1, pp. 77-83

  2. Negative symptoms and executive function in schizophrenia: Does their relationship change with illness duration?

    Psychopathology, Vol. 46, Núm. 4, pp. 241-248

  3. Randomized trial of clozapine vs. risperidone in treatment-naïve first-episode schizophrenia: Results after one year

    Schizophrenia Research, Vol. 149, Núm. 1-3, pp. 156-161

2012

  1. Déficit cognitivo en la esquizofrenia: MATRICS Consensus Cognitive Battery

    Revista de Neurologia, Vol. 55, Núm. 9, pp. 549-555

  2. Naltrexone versus acamprosate: One year follow-up of alcohol dependence treatment

    Alcohol and Alcoholism

  3. Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis

    Comprehensive Psychiatry, Vol. 53, Núm. 8, pp. 1063-1070

  4. The MATRICS consensus Cognitive battery (MCCB): Co-norming and standardization in Spain

    Schizophrenia Research, Vol. 134, Núm. 2-3, pp. 279-284